579 results for "Integration Therapy"
Epistemic Risk Reduction in Psychedelic-Assisted Therapy.
Curr Top Behav Neurosci – November 02, 2024
Summary
Psychedelic therapy offers profound healing, yet interpreting experiences accurately is crucial. Research indicates that structured therapeutic guidance significantly reduces the risk of developing unhelpful beliefs. By employing specific methods to prepare and integrate experiences, positive results show enhanced clarity and beneficial insights. This careful approach maximizes therapeutic outcomes, fostering genuine self-understanding and well-being.
Abstract
Epistemic Risk Reduction in Psychedelic-Assisted Therapy.
An Overview of Psychedelic-Assisted Therapy
EMBARK Psychedelic Therapy for Depression – April 23, 2024
Summary
A novel therapeutic model, EMBARK, is revolutionizing mental health support. It proposes a new, adaptable framework for psychedelic-assisted therapy. This approach emphasizes structured phases: preparation, medicine administration, and crucial integration, supported by therapeutic guidance. Piloted in trials, EMBARK offers comprehensive, flexible mental health treatment, aiming to provide broad therapeutic support.
Abstract
AbstractChapter 1 introduces the concept of psychedelic-assisted therapy (PAT) and the EMBARK psychedelic therapy model, a new approach to PAT and ...
Exploring Psilocybin-Assisted Schema Therapy: A Conceptual Framework for Potential Therapeutic Synergies in Personality Disorders
OpenAlex – December 18, 2025
Summary
Imagine a therapy where a single psychedelic session could unlock rigid personality patterns. Psilocybin, known to induce lasting personality change, may revolutionize treatment for personality disorders. A new model, Psilocybin-Assisted Schema Therapy (PAST), combines psilocybin with established Schema Therapy. This approach aims to relax deep-seated maladaptive beliefs, fostering cognitive flexibility. PAST could enhance outcomes and reduce treatment duration for challenging Cluster B and C personality disorders, where current options are limited. This framework outlines future studies on its potential.
Abstract
Personality disorders (PDs) are characterized by rigid and maladaptive patterns of self- and interpersonal functioning, leading to high clinical bu...
Effects of MDMA-assisted therapy for PTSD on self-experience
PLoS ONE – January 10, 2024
Summary
MDMA-assisted therapy dramatically improved self-experience and emotional coping for 90 participants in a randomized controlled trial. Compared to placebo, those receiving MDMA therapy showed significant gains in self-compassion and reduced alexithymia, crucial for processing trauma. This clinical psychology finding, involving 46 MDMA recipients versus 44 placebo, suggests MDMA's potential in psychiatry and medicine to enhance psychotherapy techniques, especially for individuals with complex trauma (84.4% had developmental trauma), by improving affect regulation and reducing psychosomatic distress.
Abstract
Introduction There is a resurgence of interest in the therapeutic potential of psychedelic substances such as 3,4-methylenedioxymethamphetamine (MD...
Development and feasibility of a mindfulness-based dance/movement therapy intervention for chronic low back pain.
Frontiers in pain research (Lausanne, Switzerland) – January 01, 2024
Summary
A novel mindfulness-based dance/movement therapy program shows promise in helping people manage chronic back pain without medication. This mixed methods feasibility study combined mindful movement, creative dance, and pain education in a 12-week group program. Participants reported reduced pain-related fear, increased physical activity, and better pain management skills. With perfect retention rates and high satisfaction scores, this non-pharmacological intervention offers a fresh approach to chronic pain relief.
Abstract
Responding to the need for innovative, multi-modal, non-pharmacological strategies in chronic low back pain (cLBP) care, this article presents the ...
Resurrecting Ancestral Familial Health: A Role for Psilocybin?
The Family Journal – August 09, 2024
Summary
A novel approach suggests high-dose psilocybin, a compound derived from chemical synthesis and alkaloids, could revolutionize family Psychology. This perspective, informed by Developmental psychology and Social psychology, proposes a family-centered therapy where a psychotherapist integrates psychedelics with interventions like family constellations. Evidence from Drug Studies indicates this model can realign modern families with our evolved social mammalian physiological design, fostering empathy, connection, and well-being. It offers a path to heal intergenerational trauma and enhance family systems.
Abstract
Background: Research investigating high-dose, high-support psilocybin-assisted therapy reports significant psychological benefits, increased consci...
Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications
Journal of Music Therapy – January 01, 2020
Summary
Music is integral to psychedelic therapy, acting as both anchor and guide during emotional and embodied experiences. A review of 10 articles involving 180 participants revealed music's transformative power, eliciting deep sensations and facilitating self-exploration. In Psychedelics and Drug Studies, compounds like psilocybin and lysergic acid diethylamide (from chemical synthesis and alkaloids) are paired with music. This highlights a crucial role for music therapy and psychotherapists in Psychology, optimizing protocols for these emerging treatments, linking to Complementary and Alternative Medicine Studies. Participant openness to music improved outcomes.
Abstract
Abstract Bonny Method of Guided Imagery and Music emerged following discontinuation of psychedelic therapy research in the early 1970s, but psyched...
Abstract C001: A pilot study of palliadelic treatment with psilocybin to reduce psychological distress and improve quality of life in patients with advanced pancreatic adenocarcinoma
Cancer Research – January 16, 2024
Summary
Psilocybin-assisted therapy has shown significant, rapid improvement in anxiety, depression, and quality of life for cancer patients. Now, an initial study is exploring this psychedelic medicine within palliative care for advanced pancreatic cancer. With a planned 12 subjects, this oncology research aims to determine how practical and safe psilocybin is for reducing mental health distress. A single 25mg psilocybin dose, combined with counseling, will assess changes in brain activity and quality of life, potentially offering a new approach to managing severe cancer-related distress.
Abstract
Abstract Background: Psychological distress is a common reaction to a cancer diagnosis and its treatment. Distress impacts quality of life, adheren...
Psilocybin: the magic medicine for depression?
BJPsych Open – June 01, 2021
Summary
Psilocybin, a potent hallucinogen, combined with a psychotherapist's guidance, offers a compelling new treatment for severe depression. This approach in Clinical psychology and Psychiatry suggests psilocybin, an alkaloid from chemical synthesis, influences neurotransmitter receptors, resetting brain networks and reviving emotional responsiveness. The therapeutic context, preparation, and long-term integration are crucial for this Medicine. Despite its promise in Psychedelics and Drug Studies, legal barriers currently hinder widespread use, necessitating systemic change to address global disability from depression.
Abstract
Aims Depression is the single largest contributor to global disability. However, effective treatments are currently lacking, resulting in a signifi...
Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders.
Journal of addiction psychiatry – January 01, 2024
Summary
Emerging research suggests trauma's impact on personality may be effectively treated with psychedelic assisted therapy. Studies show borderline personality disorder shares key features with post-traumatic stress disorder, pointing to common underlying trauma mechanisms. Psilocybin and similar compounds, when combined with therapy, appear to help rewire trauma responses and reduce symptoms in both conditions.
Abstract
Borderline personality disorder (BPD) and post-traumatic stress disorder (PTSD) share overlapping neurobiological mechanisms particularly reward de...
Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need.
Current psychiatry reports – December 01, 2024
Summary
Promising breakthroughs in psychedelic medicine show that psilocybin and LSD may effectively treat both alcohol use disorder and major depressive disorder simultaneously. These conditions frequently occur together, making traditional treatments challenging. Studies reveal that psilocybin therapy significantly reduces drinking frequency and depressive symptoms, offering hope for a unified treatment approach.
Abstract
In this narrative review, we discuss evidence for psilocybin- and LSD-assisted treatment of alcohol use disorder (AUD) and major depressive disorde...
Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression
American Journal of Psychiatry – January 01, 2025
Summary
Rapid antidepressant effects are emerging from psychedelics. Unlike classical medicine, hallucinogens like psilocybin and ultra-fast compounds such as 5-MeO-DMT show significant promise in psychiatry. Early pharmacology studies in small samples indicate brief 15-30 minute interventions induce marked improvement in depression symptoms within 24 hours, lasting over a week. These monoamine neurotransmitters primarily act on serotonergic 5-HT receptors, influencing serotonin pathways. This neuroscience, exploring chemical synthesis and how receptors influence behavior, is vital for future psychology and drug studies.
Abstract
Unlike classical antidepressants, psychedelics such as psilocybin have been shown to induce a rapid antidepressant response. In the wake of this de...
Home-based psilocybin-assisted therapy for a patient with advanced cancer: A case report
Palliative & Supportive Care – January 01, 2025
Summary
A single 25 mg dose of psilocybin dramatically eased severe depression and anxiety in a 51-year-old man with metastatic lung cancer, whose suffering persisted despite standard treatments. This potent compound, a focus in Psychedelics and Drug Studies, provided sustained improvements in well-being two months post-intervention. Delivered safely in a homecare setting, this form of Complementary and Alternative Medicine Studies offers a promising, long-lasting treatment for existential distress in palliative care. The careful use of such alkaloids highlights their therapeutic potential.
Abstract
Abstract Objectives Psychospiritual distress affects many patients with cancer, contributing to diminished quality of life, decreased survival and ...
Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement.
JAMA network open – June 03, 2024
Summary
Integrating psychedelic medicine ethically is crucial. A diverse panel of 27 experts recently forged 20 points of consensus on 5 key ethical issues for future clinical care. Their work provides a vital framework for professional boundaries, informed consent, and equitable access, marking a significant step toward safe and responsible therapeutic use.
Abstract
As government agencies around the globe contemplate approval of the first psychedelic medicines, many questions remain about their ethical integrat...
Exploring the Role of Psychedelics in Modulating Ego and Treating Neuropsychiatric Disorders.
ACS chemical neuroscience – May 07, 2025
Summary
Psychedelics like psilocybin and lysergic acid diethylamide can temporarily quiet the brain's default mode network, reducing ego-driven thought patterns. This disruption appears key in treating neuropsychiatric diseases. Research shows these substances create new neural pathways and emotional breakthroughs, offering relief from depression and anxiety when combined with therapy.
Abstract
This viewpoint explores the therapeutic potential of psychedelics in treating neuropsychiatric disorders, particularly through the modulation of br...
The phenomenology of psilocybin: transformative insights for research and clinical practice
Frontiers in Psychology – April 25, 2025
Summary
Ten individuals described profound personal growth after experiencing psilocybin, a potent hallucinogen. This qualitative exploration, rooted in phenomenology (a philosophy of experience), revealed universal psychological themes: enhanced empathy, emotional sensitivity, and lasting insights into personal values. Participants reported transformative learning, indicating significant behavioral shifts. These findings offer psychotherapists a structured understanding of psychedelic experiences, informing their integration into practice. Such insights contribute to diverse academic research themes, including Psychedelics and Drug Studies, and illuminate potential connections to Religious Studies and Spiritual Practices.
Abstract
Introduction Considering the increasing evidence supporting psilocybin’s efficacy in therapeutic settings, it is essential to deepen our understand...
Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview.
American journal of therapeutics
Summary
Psychedelic medicines are reemerging as powerful tools for mental health treatment, with breakthrough results in treating depression, anxiety, and PTSD. Recent clinical trials show promising outcomes, particularly with MDMA for PTSD and psilocybin for depression. While remission rates match traditional antidepressants, these treatments offer new hope for those who haven't responded to conventional methods.
Abstract
Psychedelic drugs have recently emerged as plausibly effective pharmacological agents for the management of depression, anxiety, and other neuropsy...
Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings
Brain and Behavior – July 01, 2025
Summary
Veterans attending psychedelic retreats experienced significant mental health improvements. Among 58 participants, Ayahuasca or Psilocybin therapy led to a 29.1% reduction in depression (Patient Health Questionnaire) and 26.1% in PTSD. Psilocybin generally led to greater improvements, though Ayahuasca provided a 26.4% improvement for PTSD, surpassing psilocybin's 24.8%. Women with PTSD saw a 32.1% improvement, compared to 24.1% for men. Those with more severe initial symptoms benefited most, highlighting a promising framework in psychiatry and medicine for enhancing quality of life via natural compound pharmacology.
Abstract
Abstract Background : Military veterans are at risk of various mental health conditions, with profound implications for post‐deployment quality of ...
Psychedelic Therapy: A Primer for Primary Care Clinicians—Historical Perspective and Overview
American Journal of Therapeutics – March 01, 2024
Summary
MDMA, a synthetic drug, demonstrates superiority over existing treatments for post-traumatic stress disorder in two completed Phase III clinical trials. This highlights the growing potential of psychedelics as medicine in psychiatry. While psilocybin, a naturally occurring hallucinogen, shows a 25-29% depression remission rate in larger trials (100+ participants)—comparable to standard antidepressants at 30%—other compounds like lysergic acid diethylamide and the dissociative Esketamine are also being explored. Understanding their pharmacology and potential adverse effects is crucial as these drug studies advance.
Abstract
Background: Psychedelic drugs have recently emerged as plausibly effective pharmacological agents for the management of depression, anxiety, and ot...
Cannabis-assisted psychotherapy for complex dissociative posttraumatic stress disorder: A case report
Frontiers in Psychiatry – February 09, 2023
Summary
A young woman with complex dissociative posttraumatic stress disorder achieved a 98.5% reduction in pathological dissociation after ten sessions of cannabis-assisted psychotherapy. This psychotherapist-guided treatment combined cognitive and exposure therapies to address severe depersonalization and derealization, common in dissociative and panic disorders. Improved cognition and psychosocial functioning were sustained for over two years. Offering a promising avenue for clinical psychology and psychiatry, it links cannabis to psychedelics and their Neurotransmitter Receptor Influence on Behavior.
Abstract
Background A dissociative subtype of posttraumatic stress disorder, known as “D-PTSD”, has been included in the Diagnostic and Statistical Manual o...
From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.
Expert review of clinical pharmacology – June 11, 2025
Summary
Breakthrough research reveals psychedelic compounds like psilocybin and LSD can rapidly alleviate depression through multiple interconnected pathways. Unlike traditional antidepressants, these substances work by simultaneously affecting brain chemistry, psychological patterns, and consciousness. The therapeutic effects emerge from a complex interplay of biological changes and meaningful experiences during psychedelic-assisted therapy.
Abstract
Psychedelic compounds are emerging treatments for depression, capable of producing rapid and lasting symptom reduction after 1-2 administrations in...
Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper
European Psychiatry – January 01, 2025
Summary
The "Renaissance" in **Psychedelics and Drug Studies** is rapidly reshaping **Psychiatry**, with treatments like **Psilocybin** for depression nearing formal regulation. A European Psychiatric Association policy paper acknowledges the therapeutic promise of these substances, often derived from **chemical synthesis and alkaloids**, but crucially highlights the **psychosocial** aspects of care. Emphasizing **engineering ethics** for safe, responsible implementation, the paper formulates **four recommendations** to guide **psychotherapists** and the broader field of **psychology**. This approach ensures these emerging **Complementary and Alternative Medicine Studies** integrate ethically and effectively.
Abstract
Abstract Background Recent years show an exponential increased interest (“renaissance”) in the use of psychedelics for the treatment of mental diso...
Exploring the Use of Psilocybin Therapy for Existential Distress: A Qualitative Study of Palliative Care Provider Perceptions
Journal of Psychoactive Drugs – July 16, 2021
Summary
Psilocybin offers a promising avenue for alleviating existential distress in palliative care. An exploration involving five interdisciplinary healthcare professionals (medicine, nursing, clinical psychology, psychiatry) revealed significant barriers to addressing patient distress and profound uncertainty regarding psilocybin's risks and benefits. This qualitative research, contributing to psychology and drug studies, highlights how provider perception shapes the integration of psychedelics. Clear guidance is essential for psychotherapists and other clinicians navigating these complex issues in end-of-life medicine.
Abstract
There is a growing body of research suggesting that palliative care patients coping with existential distress may benefit from psilocybin. However,...
Psychedelic integration and transformation
Consciousness, Spirituality & Transpersonal Psychology – December 22, 2023
Summary
Beyond the trip itself, psychedelic experiences can lead to lasting positive changes when properly integrated into daily life. Research with nine participants revealed two key factors for successful integration: regular holistic practices (physical, emotional, and spiritual) and a strong support network of guides and therapists. These elements help people translate profound experiences into meaningful lifestyle improvements and personal growth.
Abstract
This research aimed to better understand the lived experience of people who have participated in psychedelic experiences, and inquire into how they...
MDMA-Assisted Treatment for PTSD, Anxiety, and Depression: A Visualized Literature Analysis over 30 Years.
Current medicinal chemistry – June 02, 2025
Summary
Over three decades of research reveals MDMA-assisted therapy shows remarkable promise in treating PTSD, anxiety, and depression. Analysis of 30 years of scientific literature shows a dramatic shift from studying MDMA's risks to exploring its therapeutic benefits. The U.S. leads research efforts, with breakthrough results demonstrating MDMA's potential to help patients process trauma and emotional distress in controlled therapeutic settings.
Abstract
The incidence of psychiatric disorders, such as post-traumatic stress disorder (PTSD), anxiety, and depression, has been steadily increasing, while...
Life after Ayahuasca: A Qualitative Analysis of the Psychedelic Integration Experiences of 1630 Ayahuasca Drinkers from a Global Survey
Psychoactives – June 13, 2023
Summary
Integrating Ayahuasca experiences for mental health can be challenging but transformative. A qualitative research survey of 1630 Ayahuasca drinkers (50.4% male) used thematic analysis to explore post-experience integration. Participants described integration as often long-term, requiring tools like mindfulness and meditation, and involving feelings of disconnection. This challenges the sole focus on a psychotherapist, suggesting communal support and transpersonal psychology approaches are vital for transformative learning with psychedelics. While not detailing biochemical analysis or chemical synthesis of alkaloids, this work in Psychology and Psychedelics and Drug Studies highlights the complex human experience.
Abstract
Ayahuasca is an Amazonian psychoactive plant medicine being explored for its potential therapeutic uses in Western contexts. Preliminary studies li...
Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis.
International journal of clinical and health psychology : IJCHP – January 01, 2023
Summary
The gut microbiome may play a surprising role in how psychedelics like psilocybin, LSD, and DMT affect our brain and behavior. Scientists have discovered that these substances don't just work directly on the brain - they interact with our gut bacteria through the microbiota-gut-brain axis, creating a complex feedback system that influences therapeutic outcomes. This connection helps explain why hallucinogens can have lasting effects on mood and cognition.
Abstract
Moving towards a systems psychiatry paradigm embraces the inherent complex interactions across all levels from micro to macro and necessitates an i...
Ketamine-Assisted Psychotherapy for Antisocial Personality Disorder: A Case Report.
Journal of psychoactive drugs – January 07, 2025
Summary
A groundbreaking case shows how ketamine-assisted psychotherapy helped transform the life of a man with antisocial personality disorder. Over three years, low-dose ketamine sessions combined with therapy helped resolve his alcoholism, reduced violent thoughts, and improved depression. This marks a potential new avenue for treating a condition that traditionally has limited treatment options.
Abstract
There are currently no evidence-based treatment guidelines for antisocial personality disorder (ASPD). Instead, treatment typically focuses on como...
Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach.
Frontiers in psychiatry – January 01, 2025
Summary
MDMA's unique ability to enhance empathy and trust may offer breakthrough treatment for pathological narcissism. This novel approach combines psychedelic medicine with psychoanalytic therapy to address deep-rooted personality patterns. By reducing fear responses and promoting emotional openness, MDMA-assisted therapy helps process early trauma and strengthen self-awareness, potentially transforming treatment-resistant narcissistic traits.
Abstract
Pathological narcissism (PN) is a complex, treatment-resistant disorder characterized by unstable self-esteem that fluctuates between grandiosity a...
Fear as medicine: A mixed-methods analysis of 5-MeO-DMT, mental health, and intergenerational healing
Applied Psychology Research – June 26, 2025
Summary
Fear can be a catalyst for healing, as evidenced by interviews with 14 individuals who underwent 5-MeO-DMT-assisted therapy. Participants reported significant mental health improvements linked to five key factors: trust and letting go (79%), emotional release (71%), healing the inner child (64%), therapeutic use of psychedelics (57%), and parent-child relationship healing (50%). Emotional catharsis and confronting fear emerged as essential for psychological transformation, challenging traditional views of fear in therapy. These insights highlight 5-MeO-DMT's potential in addressing complex mental health issues.
Abstract
Objective: This study investigates the psychological mechanisms through which 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) influences mental healt...
Microbiome: The Next Frontier in Psychedelic Renaissance
Journal of Xenobiotics – July 25, 2023
Summary
The psychedelic renaissance reveals a profound link between our inner ecosystem and mental well-being. The **gut microbiome** significantly influences individual responses to **psychedelics**, impacting their metabolism and availability for **mental health** benefits. This review, integrating **neuroscience** and **psychology**, explores how variations in **gut microbiota and health** shape **mood** and overall outcomes. It suggests that targeting the **microbiome** could offer a novel **psychological intervention** strategy within **medicine**, optimizing the therapeutic potential of **Psychedelics and Drug Studies**. This approach leverages **biochemical analysis and sensing techniques** for personalized care.
Abstract
The psychedelic renaissance has reignited interest in the therapeutic potential of psychedelics for mental health and well-being. An emerging area ...
Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation
Frontiers in Psychiatry – August 07, 2020
Summary
Psychedelics show promise in mental health, significantly reducing suicidal ideation, depression, and experiential avoidance. Across two studies involving 104 and 254 participants, individuals reported marked improvements weeks after psychedelic use. This suggests that reduced experiential avoidance, a core concept in psychology and clinical psychology, may be a key mechanism for these benefits. For medicine and psychiatry, this highlights psychedelics' potential, particularly when integrated with psychotherapeutic approaches. A psychotherapist could leverage these insights to enhance treatment for anxiety and other conditions, moving beyond traditional drug studies to a deeper understanding of behavioral change.
Abstract
Psychedelic therapy shows promise as a novel intervention for a wide range of mental health concerns but its therapeutic action is incompletely und...
Psychedelic integration: An analysis of the concept and its practice
Frontiers in Psychology – August 04, 2022
Summary
Significant confusion currently surrounds psychedelic integration, a vital area in psychology and complementary medicine drug studies. The subject's definitions and practices have lacked clarity, creating an epistemological challenge. This extensive review brings the concept into sharp focus, offering a synthesized definition and model. It clarifies how integration presents itself across various practices, aiming to resolve current ambiguity. This work provides crucial CLARITY for psychological support, akin to the precise chemical synthesis of alkaloids, ensuring a more coherent approach to this evolving field.
Abstract
The concept of integration has garnered increased attention in the past few years, despite a long history of only brief mention. Integration servic...
Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy.
Psychedelic medicine (New Rochelle, N.Y.) – September 01, 2023
Summary
Holistic approaches to healing, like those used in hospice care, could hold the key to successfully implementing psychedelic-assisted therapy in modern healthcare. By combining supportive care principles with psychedelic treatments, practitioners can address both mental health and spiritual care needs. The palliative care movement's success offers a roadmap for integrating these powerful therapies while maintaining their human-centered, psychosocial focus.
Abstract
Psychedelic-assisted therapy (PAT) has re-emerged as a promising intervention for addressing mental health conditions and existential concerns. Des...
Comparative Efficacy and Functional Outcomes of Psychedelic-Assisted Therapies in Treatment-Resistant Depression: A Systematic Review of Recent Clinical Trials.
Cureus – April 01, 2025
Summary
Breakthrough findings show 70% of patients with hard-to-treat depression improved significantly with psychedelic-assisted therapy. Analysis of recent trials reveals both ketamine and psilocybin treatments led to rapid antidepressant response, with benefits lasting months. Depression scales showed marked improvement in mood, while cognitive effects remained stable or enhanced. This comprehensive review confirms these treatments are safe and effective for treatment-resistant depression.
Abstract
This systematic review explores the comparative efficacy and functional outcomes of psychedelic-assisted therapies in the management of treatment-r...
Psilocybin as a psychophysical adaptogen in chronic pain rehabilitation.
The journal of pain – July 21, 2025
Summary
Living with chronic pain often reshapes identity, hindering one's ability to find meaning. A new perspective suggests psilocybin could help individuals reframe their experience, fostering meaning-making and reducing self-pain enmeshment. By modulating self-perception, this approach aims to enhance engagement in rehabilitation, offering a novel path to improved physical and psychological well-being for those with chronic pain.
Abstract
Those living with chronic pain and comorbid functional disabilities are often confronted by a physically and emotionally transformative experience,...
The Therapeutic Potential of Psychedelics on Reducing Rumination: A Mini-Review.
Psychedelic medicine (New Rochelle, N.Y.) – September 01, 2024
Summary
Psychedelic use is linked to significantly lower levels of rumination, a major risk factor for depression and anxiety. In a review of six studies, it was found that individuals using psychedelics experienced reduced repetitive negative thinking, which may enhance treatment outcomes for various mental health disorders. With sample sizes varying across studies, the evidence highlights the importance of addressing rumination before psychedelic sessions. Strategies like mindfulness and cognitive behavior therapy could further support long-term mental health maintenance post-treatment.
Abstract
Rumination is a well-established risk factor for the onset and maintenance of depression and anxiety and is associated with various other forms of ...
Case Report: Amplified psychoanalysis? Psychoanalysis, OCD and MDMA in a clinical case study
Frontiers in Psychology – March 11, 2026
Summary
MDMA-assisted therapy within a psychoanalytic framework shows promising potential for treating obsessive-compulsive disorder (OCD). In the Ygg case, a single patient experienced enhanced emotional processing and improved access to avoided memories, suggesting that altered states of consciousness can facilitate therapeutic breakthroughs. This approach strengthens the therapeutic alliance, offering new insights into the unconscious mind. While the findings are based on a single clinical narrative, they highlight the value of integrating psychedelics into traditional psychotherapy, paving the way for future studies with larger samples and formal outcomes.
Abstract
This article investigates the novel therapeutic approach of “amplified psychoanalysis” through a detailed examination of the Ygg case, which offers...
Cosmology of belonging: The role of community in the therapeutic use of psychedelics.
Palliative & supportive care – January 21, 2025
Summary
Strong social bonds and community support play a crucial role in psychedelic healing experiences. Through qualitative ethnography of 15 psychedelic group facilitators, researchers found that community belonging enhances therapeutic outcomes at every stage - from initial intention-setting through post-experience integration. Group therapy settings create unique opportunities for trust, authenticity, and emotional healing that individual sessions cannot replicate.
Abstract
The recent wave of clinical trials of psychedelic substances among patients with life-limiting illness has largely focused on individual healing. T...
Psilocybin and MDMA in Couples Therapy: Investigating Treatment for Substance Use Disorders and Codependency
Contemporary Family Therapy – December 11, 2025
Summary
Addressing the complex interplay of addiction and relationship dynamics, a review explores how psychedelic-assisted therapy could transform couples facing substance use disorders (SUDs). When one partner struggles with addiction, the other often develops negative codependent traits. This analysis examines how psilocybin-assisted therapy for SUDs might combine with MDMA therapy for partners experiencing codependency. Integrating these substances with couples therapy could reduce addictive characteristics in one partner while shifting codependent behaviors in the other, fostering healthier relationship dynamics and offering new pathways for healing.
Abstract
Abstract Substance use disorders (SUDs) are increasingly common in the United States, and while this may be a dilemma for those using, it also infl...
Supple bodies, healthy minds: yoga, psychedelics and American mental health.
Med Humanit – March 30, 2018
Summary
Historically, practices like yoga and psychedelics, once considered outside the mainstream, have profoundly shaped American mental health. This analysis explores how these distinct approaches became integrated into therapeutic frameworks. It reveals that both yoga's focus on physical and mental discipline and psychedelics' unique mind-altering effects have offered powerful avenues for addressing mental distress. The positive findings underscore their significant role in fostering improved well-being and new perspectives on mental care.
Abstract
Supple bodies, healthy minds: yoga, psychedelics and American mental health.
Developing Guidelines and Competencies for the Training of Psychedelic Therapists
Journal of Humanistic Psychology – June 29, 2017
Summary
Psychedelic-assisted psychotherapy significantly reduces clinical symptoms and improves quality of life, a finding supported by decades of Psychology research. Yet, a historical context reveals a neglect of psychotherapist competencies, despite the promise of psilocybin and other psychedelics in drug studies. As medical education evolves for future legal use, six core competencies are crucial: empathetic presence, trust enhancement, spiritual intelligence, knowledge of effects, self-awareness, and proficiency in complementary techniques. A curriculum of 12 domains will guide training for these vital skills.
Abstract
Research since the 1950s has shown that psychedelic-assisted psychotherapy has had significant positive effects in reductions of specific clinical ...
Can Psychedelic Use Benefit Meditation Practice? Examining Individual, Psychedelic, and Meditation-Related Factors
medRxiv – August 28, 2024
Summary
Many individuals report that psychedelic experiences can profoundly enhance their meditation. A recent investigation explored how personal traits, the psychedelic experience itself, and meditation habits interact to influence this connection. Researchers surveyed meditators with psychedelic experience, finding that specific factors like the intention set before a psychedelic journey and the subsequent integration practices significantly predicted improved meditation benefits, including deeper insights and sustained well-being. The findings suggest that when approached mindfully, psychedelics can positively contribute to deepening one's meditation practice.
Abstract
Can Psychedelic Use Benefit Meditation Practice? Examining Individual, Psychedelic, and Meditation-Related Factors
Culture, context, and ethics in the therapeutic use of hallucinogens: Psychedelics as active super-placebos?
Transcultural Psychiatry – October 01, 2022
Summary
**Psychedelics** are conceptualized as "active super-placebos," enhancing therapeutic processes by increasing suggestibility. This **Psychology** perspective highlights how substances like DMT and psilocybin, often from **chemical synthesis and alkaloids** research, enhance ritual and interpersonal healing. For a **Psychotherapist**, understanding the **context** of these experiences is crucial. **Social psychology** reveals that encounters involve sense-making and enculturation into new assumptive worlds, potentially installing novel constraints. Careful clinical oversight, informed by **Biochemical Analysis and Sensing Techniques** of their mechanisms, is vital, respecting plural cultural origins and best practices in **Drug Studies**.
Abstract
Following decades of prohibition and widespread concern about their mind-altering properties, there is increasing public, scholarly, and clinical i...
Managing psychological distress in women with breast cancer: A systematic review of intervention trends in the past decade.
Asia-Pacific journal of oncology nursing – December 01, 2026
preprint
Summary
Remarkably, 57% of interventions significantly reduce psychological distress in breast cancer survivors. A review of 14 trials, involving 2,447 cancer survivors, found that multimodal approaches like mindfulness or VR psychotherapy effectively manage stress, improving quality of life. These interventions achieved small to large effects (Cohen's d = 0.44-1.54). Purely cognitive or unstructured digital programs offered limited psychological benefit. Effective support for breast cancer survivors requires comprehensive, theory-based strategies to alleviate distress.
Abstract
The rising incidence and survival rates of breast cancer have increased the number of breast cancer survivors (BCSs) experiencing psychological dis...
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors.
J Psychopharmacol – February 28, 2023
Summary
Psychedelic-assisted group therapy shows promise in creating deeper emotional connections and accelerating healing. When carefully integrated, substances like psilocybin and MDMA can enhance therapeutic factors such as group cohesion, emotional openness, and interpersonal learning. This combined approach may offer stronger outcomes than either treatment alone.
Abstract
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors.
Psilocybin-Assisted Compassion Focused Therapy for Depression
Frontiers in Psychology – March 25, 2022
Summary
Psilocybin, a potent hallucinogen, demonstrates significant efficacy, with studies showing it reduces depressive symptoms by over 50% for many patients. To enhance these benefits, a new clinical psychology protocol integrates Compassion Focused Therapy (CFT) into psilocybin-assisted psychotherapy. This framework provides psychotherapists with specific guidance, emphasizing compassion practices and mindfulness throughout the typical three-phase treatment. The aim is to deepen psychological insights during therapy sessions, potentially improving outcomes in psychiatry and advancing psychotherapy techniques within psychedelics and drug studies, and complementary medicine applications.
Abstract
Psilocybin-assisted psychotherapy, i.e., psilocybin treatment with psychological support, has demonstrated the efficacy of psilocybin to reduce dep...
The Effects of Psychotherapy on Single and Repeated Ketamine Infusion(s) Therapy for Treatment-Resistant Depression: The Convergence of Molecular and Psychological Treatment.
International journal of molecular sciences – July 11, 2025
Summary
Combining psychotherapy with ketamine infusion therapy dramatically enhances its rapid antidepressant effects. A review of patient data showed that N-methyl-D-aspartate (NMDA) receptor antagonists like ketamine promote neuroplasticity, creating a unique window for therapeutic change. For treatment-resistant depression (TRD), those receiving ketamine-assisted psychotherapy (KAP) experienced the most pronounced symptom reduction, highlighting the benefits of integrated care.
Abstract
Ketamine infusion therapy has gained recognition as an innovative treatment for treatment-resistant depression (TRD), demonstrating rapid and robus...
Introduction: Psychedelic Science Needs Philosophy
Philosophy and the Mind Sciences – April 19, 2022
Summary
Understanding the profound impact of psychedelics requires more than just science. A key insight reveals that integrating philosophical thought is vital for advancing modern psychedelic therapy. This approach argues that philosophical inquiry offers essential frameworks for interpreting complex experiences and ethical considerations. By embracing this perspective, the field gains deeper insights into therapeutic mechanisms, ensuring responsible and effective development. This integration is foundational for shaping the future of psychedelic medicine.
Abstract
I highly recommend Philosophy of Psychedelics by Chris Letheby (2021) to both the public and academics who want to dig deeper into the modern thera...
The Role and Ethics of Touch and Non-touch in Psychedelic-Assisted Therapy.
Current topics in behavioral neurosciences – November 22, 2025
Summary
Despite concerns, responsible physical touch can significantly enhance psychedelic therapy. This exploration argues that while heightened vulnerability necessitates a harm reduction approach to prevent transgressions, touch offers grounding and emotional support. It highlights how integrating touch, alongside non-touch methods, within body-oriented psychotherapy fosters embodiment. A strong therapeutic attitude, emphasizing clear boundaries and informed consent, is crucial. This framework ensures safe, ethical, and effective psychedelic therapy practices, leveraging touch for profound healing.
Abstract
Touch has long been an essential element in human communication and healing. In the field of psychedelic-assisted therapy (PAT), the role of touch ...